INDOVAX PVT LTD

Gurugram-based poultry biotechnology company Indovax recorded a revenue generation of Rs 80 crore in the biopharma space during FY 20-21, exhibiting a growth of 7 per cent as compared to the revenue generation of Rs 74 crore during FY 19-20. The company’s product portfolio contains 12 live vaccines and 11 inactivated poultry vaccines. Incorporated in 1986, the company produces over four billion doses of poultry vaccine annually that cater to the needs of the domestic and international markets. This effort is supported by a team of qualified scientists drawn from diverse disciplines.